OTCMKTS:CAPS Capstone Therapeutics (CAPS) Stock Forecast, Price & News $7.50 0.00 (0.00%) (As of 09/29/2023 ET) Add Compare Share Share Today's Range$7.50▼$7.5050-Day Range$7.50▼$7.5052-Week Range$5.00▼$20.00VolumeN/AAverage Volume5 shsMarket Capitalization$600,000.00P/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsFinancialsHeadlinesSEC FilingsProfileChartCompetitorsFinancialsHeadlinesSEC Filings About Capstone Therapeutics (OTCMKTS:CAPS) StockCapstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.Read More CAPS Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CAPS Stock News HeadlinesSeptember 30, 2023 | finance.yahoo.comSatya Therapeutics Provides Business Update on Psilocybin Service Center and Psilocybin Manufacturing OperationsAugust 28, 2023 | finanznachrichten.deCapstone Therapeutics Corp: Capstone Holding Corp. Announces CFO ChangeSeptember 30, 2023 | Chaikin Analytics (Ad)This is the #1 Stock to Buy for the AI Tidal WaveMarc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.August 28, 2023 | finance.yahoo.comCapstone Holding Corp. Announces CFO ChangeMay 17, 2023 | nasdaq.comCapstone Green Energy Corporation Common Stock (CGRN)February 19, 2023 | bizjournals.comDobbins, Capstone developing apartment complex in FloridaFebruary 15, 2023 | finance.yahoo.comCapstone Copper Reports Fourth Quarter and Full-Year 2022 Financial ResultsDecember 29, 2022 | marketwatch.comStudent Premium Private Hostels, Studios and Housing Market (New Report) 2023 Is Flourishing Around the World by 2029 | 127 Pages ReportSeptember 30, 2023 | Weiss Ratings (Ad)Guess What The Fed Is Doing To Your Money Now?For years, the Federal Reserve has been printing mountains of money jacking up interest rates and driving the U.S. into a recession. And just a few weeks ago, they did something even more disturbing. And hardly anyone is talking about it. Yet this could harm you more than money printing and interest rates. It made a frightening power grab of the U.S. dollar, and it could cause you to lose control of your cash.September 18, 2022 | uk.finance.yahoo.comGlobal Head and Neck Cancer Therapeutics Market Report 2022: Advances in Biochemistry and Genomics Fuels SectorSeptember 15, 2022 | finance.yahoo.comCapStone Holdings Inc. and Gamers Outreach Bring Gaming to Children's Hospitals in St. LouisSeptember 15, 2022 | reuters.comCapstone Therapeutics CorpSeptember 9, 2022 | yahoo.comHormel Foods announces free downtown concertSeptember 7, 2022 | stockhouse.comADC Therapeutics to Participate in Morgan Stanley's 20th Annual Global Healthcare ConferenceAugust 19, 2022 | nz.finance.yahoo.comKriya Appoints Pedro Huertas M.D., Ph.D., as Chief Medical Officer of its Rare Disease DivisionJuly 12, 2022 | uk.finance.yahoo.comMax Q: GroundedJune 21, 2022 | finanznachrichten.deCapstone Therapeutics Corp: Capstone Holding Corp. Announces Exercise Of Secured Debt And Interest Conversion Option By Majority Shareholder,May 21, 2022 | yahoo.comEverything you need to know about NASA’s historic CAPSTONE launchMarch 16, 2022 | insidermonkey.com10 Stocks to Buy Now According to Leonard A. Potter’s Wildcat Capital ManagementMarch 15, 2022 | finance.yahoo.comCapstone To Provide Resilient Power System For New Plant In MarylandMarch 15, 2022 | seekingalpha.comCapstone Green Energy to provide power system for Maryland cell therapy plantFebruary 26, 2022 | finanznachrichten.deCapstone Therapeutics Corp. Announces Name Change to Capstone Holding Corp.December 2, 2021 | finance.yahoo.comCapstone Therapeutics Corp. Announces Results of Annual MeetingDecember 1, 2021 | uk.finance.yahoo.comMANA Therapeutics Announces Final Closing of Series A and Closing of Venture Debt FacilityAugust 25, 2021 | baystreet.caStocks Build on GainsAugust 23, 2021 | nasdaq.comCanadian Market Firmly Up In Positive Territory; Trillium Therapeutics SkyrocketsAugust 18, 2021 | msn.comNew 130K square-foot drug manufacturing plant in Seattle area will develop COVID-19 therapeuticsSee More Headlines Receive CAPS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Capstone Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address CAPS Company Calendar Last Earnings8/13/2018Today9/30/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:CAPS CUSIPN/A CIK887151 Webwww.capstonethx.com Phone(708) 371-0660Fax602-286-5300Employees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares80,000Free Float45,000Market Cap$600,000.00 OptionableNot Optionable Beta131.81 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Michael M. Toporek (Age 57)CEO, Pres & Chairman Edward SchultzVP,CFO & TreasurerMr. Matthew E. Lipman (Age 44)VP, Sec. & Director Key CompetitorsPLx PharmaNASDAQ:PLXPArgos TherapeuticsOTCMKTS:ARGSQOncorusNASDAQ:ONCRAmarantus BioScienceOTCMKTS:AMBSSciSparcNASDAQ:SPRCView All Competitors CAPS Stock - Frequently Asked Questions How have CAPS shares performed in 2023? Capstone Therapeutics' stock was trading at $37.00 on January 1st, 2023. Since then, CAPS shares have decreased by 79.7% and is now trading at $7.50. View the best growth stocks for 2023 here. How were Capstone Therapeutics' earnings last quarter? Capstone Therapeutics Corp. (OTCMKTS:CAPS) announced its quarterly earnings data on Monday, August, 13th. The biotechnology company reported $0.02 EPS for the quarter. The biotechnology company earned $2 million during the quarter. What other stocks do shareholders of Capstone Therapeutics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Capstone Therapeutics investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Akero Therapeutics (AKRO), CymaBay Therapeutics (CBAY), Cumberland Pharmaceuticals (CPIX), Entasis Therapeutics (ETTX), Evelo Biosciences (EVLO), Kaleido Biosciences (KLDO). What is Capstone Therapeutics' stock symbol? Capstone Therapeutics trades on the OTCMKTS under the ticker symbol "CAPS." How do I buy shares of Capstone Therapeutics? Shares of CAPS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Capstone Therapeutics' stock price today? One share of CAPS stock can currently be purchased for approximately $7.50. How much money does Capstone Therapeutics make? Capstone Therapeutics (OTCMKTS:CAPS) has a market capitalization of $600,000.00. How can I contact Capstone Therapeutics? Capstone Therapeutics' mailing address is 1275 W. Washington Street Suite 104, Tempe AZ, 85281. The official website for the company is www.capstonethx.com. The biotechnology company can be reached via phone at (708) 371-0660, via email at investorinquiries@capstonethx.com, or via fax at 602-286-5300. This page (OTCMKTS:CAPS) was last updated on 9/30/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Capstone Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.